Mckesson Specialty Health Pharmaceutical & Biotech Solutions LLC
UEI GWZXFMRKFS27 · TX · subsidiary of Mckesson Corporation · SAM.gov record ↗
$24K
FY2025 obligations
2
Contract awards
Sep 19, 2023
First action
Sep 22, 2025
Latest action
Obligations by agency
- Department Of Veterans Affairs$24K
- Department Of Health And Human Services$0
Obligations by NAICS
Monthly obligations
May 25
Sep 25
Largest awards
- 36C25725P0508 ↗$24K
HUMATIN USP CAPS 250MG
- Ends
- Jun 26, 2025
- Started
- May 27, 2025
- Agency
- Department Of Veterans Affairs
- NAICS
- 325412
P00002 - REVISING DELIVERABLES WITHIN THE SOW ----LEVERAGING REAL-WORLD DATA (RWD) TO INVESTIGATE THE NATURAL HISTORY OF RARE CANCERS TREATED IN THE US COMMUNITY ONCOLOGY SETTING TO PROVIDE CLINICAL CONTEXT TO INFORM FUTURE RESEARCH
- Ends
- Sep 28, 2028
- Started
- Sep 19, 2023
- Agency
- Food And Drug Administration
- NAICS
- 541720
| PIID | Description | Agency | NAICS | Obligated | Start | End |
|---|---|---|---|---|---|---|
| 36C25725P0508 ↗ | HUMATIN USP CAPS 250MG | Department Of Veterans Affairs | 325412 | $24K | May 27, 2025 | Jun 26, 2025 |
| 75F40123C00199 ↗ | P00002 - REVISING DELIVERABLES WITHIN THE SOW ----LEVERAGING REAL-WORLD DATA (RWD) TO INVESTIGATE THE NATURAL HISTORY OF RARE CANCERS TREATED IN THE US COMMUNITY ONCOLOGY SETTING TO PROVIDE CLINICAL CONTEXT TO INFORM FUTURE RESEARCH | Food And Drug Administration | 541720 | $0 | Sep 19, 2023 | Sep 28, 2028 |